- Cell Biology
- Product Type
- Research Area
- New Products
- About Tocris
- Contact Us
Osteogenic stem cells are derived from mesenchymal stem cells, and can differentiate into osteoblasts and chondroblasts.
|Cat. No.||Product Name / Activity|
|AMPK activator; promotes osteogenic differentiation of bone marrow-derived MSCs|
|Promotes osteogenic differentiation in MSCs|
|PKA signaling activator; promotes osteogenesis from hMSCs|
|Smo receptor agonist; induces differentiation of mesenchymal progenitor cells into osteoblasts|
|gp130 modulator; promotes chondrocyte activation|
Tocris offers the following scientific literature for Osteogenic Stem Cells to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Written by Kirsty E. Clarke, Victoria B. Christie, Andy Whiting and Stefan A. Przyborski, this review provides an overview of the use of small molecules in the control of stem cell growth and differentiation. Key signaling pathways are highlighted, and the regulation of ES cell self-renewal and somatic cell reprogramming is discussed. Compounds available from Tocris are listed.
Stem cells have potential as a source of cells and tissues for research and treatment of disease. This poster summarizes some key protocols demonstrating the use of small molecules across the stem cell workflow, from reprogramming, through self-renewal, storage and differentiation to verification. Advantages of using small molecules are also highlighted.